Earnings
Home›Earnings›Previews›Benzinga highlights Revive Therapeutics and Antares Ph…
Benzinga highlights Revive Therapeutics and Antares Pharma as penny stocks to watch
The list notes Revive Therapeutics has a $101.5 million market cap, with average daily volume of 3.5 million shares, while also citing 52-week price ranges and a 1-year return for the stock.
Benzinga’s penny-stock roundup points investors to Revive Therapeutics Ltd. and Antares Pharma Inc., framing both as part of the broader healthcare sector’s growth backdrop.
For Revive Therapeutics, the article says the company focuses on research and development for rare disorders and infectious diseases and highlights that it has received FDA approvals tied to cannabidiol, psilocybin, and Bucillamine for treating diseases.
The piece also provides trading and performance figures for Revive Therapeutics, including a $101.5 million market cap, average daily volume of 3.5 million shares, a 52-week low of $0.26, a 52-week high of $0.70, and a 1-year return of 56.5%.
Antares Pharma is described as a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies, with the article citing OTREXUP among its products.